COVID-19 is now endemic, constantly changing and evolving. The health system is under rising pressure at all points, and therefore a concerted approach to prevent and minimize disease is increasingly needed
In this Product Explainer, Paediatrician and Paediatric Immunologist Prof Peter Richmond explains how Meningococcal serogroup B (MenB) disease remains the most common cause of IMD in children, adolescents and young adults, and provides an overview of the real-world evidence for MenB vaccines, and conversation strategies for use with families in general practice (6 mins).
Transitioning our patients to Novavax and protein-based vaccines and away from mRNA. Monkeypox should be taken seriously... especially for high-risk patients
Some ‘basic’ influenza epidemiology, what happened in 2021 and what to expect in 2022, what's new with cell culture influenza vaccines and high dose influenza vaccines, and importance of vaccination rates
As the world gets used to living with COVID, especially this latest infectious but not particularly severe Omicron strain, more attention is focusing on long COVID.
It is likely that Japanese encephalitis will become endemic, and GPs will once again be at the forefront in diagnosis, future immunisation programmes and patient education
It is likely that Japanese encephalitis will become endemic, and GPs will once again be at the forefront in diagnosis, future immunisation programmes and patient education
It is likely that Japanese encephalitis will become endemic, and GPs will once again be at the forefront in diagnosis, future immunisation programmes and patient education